erythrocin 1000 mg/20 ml
raztopina za injiciranje - eritromicin
erythrocin 300 mg/6 ml
raztopina za injiciranje - eritromicin
erythrocin iv lactobionate prašek za raztopino za infundiranje
lenis d.o.o. - prašek za raztopino za infundiranje - eritromicin
erythromycin lactobionate 1g liofilizat
sanolabor, d.d. - liofilizat za raztopino za injiciranje - eritromicin
erythromycin stragen 1 g prašek za raztopino za infundiranje
altamedics d.o.o. - prašek za raztopino za infundiranje - eritromicin
erythromycin rotexmedica 1 g prašek za raztopino za infundiranje
sanolabor, d.d. - prašek za raztopino za infundiranje - eritromicin
erythromycin stragen 1g, prašek za raztopino za infundiranje
altamedics d.o.o. - prašek za raztopino za infundiranje - eritromicin
erythromycin inresa 1 g prašek za raztopino za infundiranje
eritromicin - prašek za raztopino za infundiranje - eritromicin 1 g / 1 viala - eritromicin
erythrocin 100 mg/20 ml
raztopina za injiciranje - eritromicin
mircera
roche registration gmbh - metoksi polietilen glikol-epoetin beta - anemia; kidney failure, chronic - antianemični preparati - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.